Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up


Phase 3
18 Years
N/A
Open (Enrolling)
Both
Non-Small-Cell Lung Carcinoma

Thank you

Trial Information

Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up


Inclusion Criteria:



- completely resected stage I, II, IIIa, and T4 due to satellite tumor nodule(s) N0-2
NSCLC

Exclusion Criteria:

- stage IIIb to IV NSCLC

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Compare overall survival for each arm

Outcome Time Frame:

6-month

Safety Issue:

Yes

Principal Investigator

Virginie Westeel, Pr

Investigator Role:

Principal Investigator

Investigator Affiliation:

Centre Hospitalier Universitaire de Besancon

Authority:

France: Ministry of Health

Study ID:

IFCT-0302

NCT ID:

NCT00198341

Start Date:

January 2005

Completion Date:

December 2015

Related Keywords:

  • Non-Small-Cell Lung Carcinoma
  • Post-surgical Non-small cell lung cancer
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location